Flora Peyvandi Shares Study on Anticoagulants and Ischemic Stroke Risk in Cancer-Associated VTE
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
“Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism.
Ischemic stroke is a common occurrence after cancer-associated VTE and may occur more frequently in patients treated with DOACs.”
Title: Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism
Authors: Sirui Ma, Yu-Cheng Chang, Cho Han Chiang, Junmin Song, Yu-Che Lee, Ko-Yun Chang, Robert A Redd, Thita Chiasakul, Ellen P. McCarthy, Jeffrey I. Zwicker, Rushad Patell, Avi Leader
Read the full article here.
Stay informed with Hemostasis Today.
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge